🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆
Clinical Trials in Poland / NCT06589557
Unknown Not applicable

Diagnostic Methods and VR Therapy for Cervical Spine Discopathy

NCT06589557 · tracked via the Priya Life Science Poland tracker
Phase
Not applicable
Started
2024-09-01
Last updated
2024-09-19

Condition(s) studied

Disability EvaluationRecovery of Function

Investigational drug(s) / intervention(s)

Virtual Reality (VR) and Standard RehabilitationStandard Rehabilitation

Virtual Reality (VR) and Standard Rehabilitation: VR Rehabilitation: The VR therapy includes exercises designed to improve the range of motion, coordination, and spatial awareness of the cervical spine. Each patient will complete 15 training sessions over three weeks (5 sessions per week, 2 hours per session), with an additional 30 minutes of daily VR exercises. Standard Rehabilitation Program: Manual Therapy: Mobilization and manipulation techniques are applied to enhance the mobility of the cervical spine joints. Proprioceptive Exercises: These exercises focus on improving body position awareness, movement, and balance. Strengthening and Stretching Exercises: Individually tailored exercises are provided to strengthen and stretch the neck muscles.

Standard Rehabilitation: Patients in this group will participate solely in the standard rehabilitation program. Standard Rehabilitation Program: Number of Sessions: Each patient will complete 15 training sessions, held 5 times per week for 3 weeks, with each session lasting 2 hours. Program Components: Manual Therapy: Mobilization and manipulation techniques will be applied to improve the mobility of the cervical spine joints. Proprioceptive Exercises: These exercises aim to enhance body position awareness, movement control, and balance. Strengthening and Stretching Exercises: Customized exercises will be provided to strengthen and stretch the neck muscles, tailored to individual needs.

Study summary

The study will assess modern diagnostic methods and evaluate the rehabilitation effects of virtual reality (VR) therapy in patients with cervical spine discopathy.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Individuals aged 18 to 65 years. * Diagnosed and confirmed cervical spine discopathy (ICD-10: M50) through imaging studies (X-ray, MRI). * Presence of symptoms related to cervical spine dysfunction, such as neck pain, limited range of motion, and radiating pain to the arms. * Informed consent to participate in the study and willingness to adhere to rehabilitation recommendations. Exclusion Criteria: * Active rheumatic diseases, cancers, advanced diabetes, cardiovascular diseases, or other conditions affecting the safety and effectiveness of rehabilitation. * Cervical spine surgeries performed within the last 6 months. * Cervical spine injuries, including fractures or dislocations. * Severe mental disorders. * Lack of informed consent to participate in the study.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Andżelina Wolan-Nieroda Rzeszów Al. Rejtana 16C

More University of Rzeszow trials in Poland

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06589557 on ClinicalTrials.gov ↗ ← All trials in Poland